[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 4525 Introduced in Senate (IS)]
<DOC>
119th CONGRESS
2d Session
S. 4525
To prohibit certain federally funded research collaborations with
certain foreign entities, and for other purposes.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
May 14, 2026
Mr. Banks introduced the following bill; which was read twice and
referred to the Committee on Homeland Security and Governmental Affairs
_______________________________________________________________________
A BILL
To prohibit certain federally funded research collaborations with
certain foreign entities, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Securing Innovation and Research
from Adversaries Act''.
SEC. 2. PROHIBITION ON FEDERALLY FUNDED RESEARCH RELATIONSHIPS WITH
CERTAIN FOREIGN ENTITIES.
(a) Prohibition.--No Federal funds awarded through a federally
funded research award may be used by an individual or entity described
in subsection (b) to enter into, support, or carry out any research
collaboration with--
(1) an entity listed on a United States Government
restricted entity list; or
(2) an individual associated with such an entity.
(b) Individual or Entity Described.--An individual or entity
described in this subsection is an individual or entity participating
in, receiving, or performing work under a federally funded research
award.
(c) Guidance.--To carry out this section, the Director of the
Office of Science and Technology Policy, in consultation with the heads
of relevant Federal research agencies, shall issue Government-wide
implementation guidance to ensure standardized compliance requirements,
definitions, and enforcement mechanisms.
(d) Waiver Authority.--
(1) In general.--The head of a Federal agency may waive the
prohibition under subsection (a), on a case-by-case basis, if
such head determines--
(A) the waiver is necessary to advance the national
security interests of the United States; or
(B) the research collaboration under subsection (a)
that is the subject of the waiver is essential for a
clearly defined scientific, public health, or national
security purpose that cannot reasonably be achieved
without such collaboration.
(2) Report.--Not later than 30 days after granting a waiver
under paragraph (1), the head of the Federal agency who granted
the waiver shall submit to Congress a written notification that
includes the following:
(A) The identity of the individual or entity that
is the subject of waiver.
(B) The justification for such waiver.
(C) The mitigation measures implemented to protect
the national security interests of the United States,
if applicable.
(e) Definitions.--In this section:
(1) Federally funded research award.--The term ``federally
funded research award'' means a grant, contract, cooperative
agreement, other Federal financial assistance (as defined in
section 200.1 of title 2, Code of Federal Regulations), or
other award issued under other transaction authority.
(2) National laboratory.--The term ``National Laboratory''
has the meaning given such term in section 2 of the Energy
Policy Act of 2005 (42 U.S.C. 15801).
(3) Research collaboration.--The term ``research
collaboration'' means any activity conducted as part of a
federally funded research award, including the following:
(A) Joint research activities or projects.
(B) Co-authorship of scholarly publications,
technical reports, or research outputs.
(C) Data or processing sharing, material transfer,
or exchange of research results, including access to
datasets, software, or research infrastructure.
(D) Joint laboratories, research centers, or
institutes.
(E) Personnel exchanges, visiting scholar
appointments, or joint supervision of students or
researchers.
(F) Any other arrangement determined by the head of
the relevant Federal research funding agency to
constitute research collaboration.
(4) United states government restricted entity lists.--The
term ``United States Government restricted entity list''
includes the following:
(A) Any of the following lists maintained by the
Bureau of Industry and Security of the Department of
Commerce:
(i) The Entity List set forth in Supplement
No. 4 to part 744 of title 15, Code of Federal
Regulations.
(ii) The Unverified List set forth in
Supplement No. 6 to part 744 of that title.
(iii) The Military End-User List set forth
in Supplement No. 7 to part 744 of that title.
(iv) The Denied Persons List maintained
pursuant to section 764.3(a)(2) of that title.
(B) The list of specially designated nationals and
blocked persons maintained by the Office of Foreign
Assets Control of the Department of the Treasury
(commonly referred to as the ``SDN list'').
(C) The list of Chinese military companies
operating in the United States required by section
1260H of the William M. (Mac) Thornberry National
Defense Authorization Act for Fiscal Year 2021 (Public
Law 116-283; 10 U.S.C. 113 note).
(D) The lists of debarred parties maintained by the
Directorate of Defense Trade Controls of the Department
of State pursuant to section 38(g)(4) of the Arms
Export Control Act (22 U.S.C. 2778(g)(4)).
(E) The list of telecommunications companies of the
People's Republic of China described in section
889(f)(3) of the John S. McCain National Defense
Authorization Act for Fiscal Year 2019 (Public Law 115-
232; 41 U.S.C. 3901 note prec.).
(F) The list of academic institutions of the
People's Republic of China maintained under section
1286(c)(9)(A) of the John S. McCain National Defense
Authorization Act for Fiscal Year 2019 (Public Law 115-
232; 10 U.S.C. 4001 note).
(G) The list of semiconductor companies of the
People's Republic of China described in section
5949(j)(3) of the James M. Inhofe National Defense
Authorization Act for Fiscal Year 2023 (Public Law 117-
263; 41 U.S.C. 4713 note).
(H) The list of biotechnology companies of concern
maintained under section 851(f) of the National Defense
Authorization Act for Fiscal Year 2026 (Public Law 119-
60; 41 U.S.C. 3901 note prec.).
(I) The list of entities that produce or provide
communications equipment or service on the list
published by the Federal Communications Commission
under section 2(a) of the Secure and Trusted
Communications Networks Act of 2019 (47 U.S.C.
1601(a)).
(J) A list maintained under clause (i), (ii), (iv),
or (v) of section 2(d)(2)(B) of the Act entitled ``An
Act to ensure that goods made with forced labor in the
Xinjiang Autonomous Region of the People's Republic of
China do not enter the United States market, and for
other purposes'', approved December 23, 2021 (Public
Law 117-78; 22 U.S.C. 6901 note), (commonly referred to
as the ``Uyghur Forced Labor Prevention Act'').
(K) The Annex to Executive Order 14032 (50 U.S.C.
1701 note; relating to addressing the threat from
securities investments that finance certain companies
of the People's Republic of China), or a successor
order.
(L) Any other list of entities designated by the
President, the Secretary of Commerce, the Secretary of
the Treasury, or the Secretary of Defense and with
which transactions are restricted or prohibited for
national security, foreign policy, or human rights
reasons.
<all>